LIMD1: A Potential Drug Target and Biomarker (G8994)

Target Name: LIMD1

NCBI ID: G8994

LIMD1

Other Name(s): LIM domains containing 1 | LIM domain-containing protein 1 | LIMD1_HUMAN | LIM domain containing 1 | hLIMD1

LIMD1: A Potential Drug Target and Biomarker

Introduction

LIM domains are a type of gene expression factor that play a crucial role in the regulation of cellular processes. These domains are composed of 25 amino acid residues and are found in various proteins, including LIM proteins, which are involved in a wide range of cellular functions, including cell signaling, development, and metabolism. One of the most well-known LIM proteins is LIMD1, which is expressed in various tissues and has been implicated in the development and progression of various diseases. In this article, we will explore the potential drug targeting and biomarker properties of LIMD1.

The Importance of LIMD1

LIMD1 is a 21 kDa protein that is expressed in various tissues, including muscle, heart, brain, and pancreas. It is highly conserved, with a sequence identity of 96% among different species. LIMD1 is involved in a wide range of cellular processes, including cell signaling, intracellular signaling, and protein synthesis.

One of the most well-known functions of LIMD1 is its role in the regulation of the myosin ATPase, a protein that is involved in muscle contraction and relaxation. LIMD1 has been shown to interact with myosin ATPase and regulate its activity. This interaction between LIMD1 and myosin ATPase is critical for muscle function and has implications for the treatment of muscle-related diseases.

Another function of LIMD1 is its role in the regulation of the unfolded protein response (UPR), a protein folding process that is critical for protein function and half-life. LIMD1 has been shown to be involved in the regulation of UPR and has implications for the treatment of diseases that are characterized by misfolded proteins, such as neurodegenerative diseases.

Potential Drug Targeting

The potential drug targeting of LIMD1 is due to its various functions and the fact that it is involved in the regulation of a wide range of cellular processes. One of the most promising drug targets for LIMD1 is the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Neurodegenerative diseases are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neuroglial plaques. These diseases are often treated with neurotransmitter replacement therapy, which can improve symptoms for a short period of time but have limited lasting effects. There is a need for more effective treatments that can slow the progression of these diseases and prevent the development of new complications.

One approach to treating neurodegenerative diseases is to target misfolded proteins, such as LIMD1, that are involved in the regulation of protein function and cell signaling. This can be achieved by inhibiting the activity of LIMD1 or by targeting its interacting proteins.

In addition to its potential therapeutic uses, LIMD1 is also a potential biomarker for neurodegenerative diseases. The misfolded proteins that are involved in these diseases can be detected using LIMD1 as a protein biomarker. This can be used to diagnose neurodegenerative diseases at an early stage and to monitor the effectiveness of different treatments.

Biomarker Potential

LIMD1 has been shown to play a role in the regulation of various cellular processes, including cell signaling and protein synthesis. It is involved in the regulation of the myosin ATPase, the unfolded protein response, and protein synthesis.

In addition to its functions in cellular processes, LIMD1 has also been shown to play a role in the regulation of inflammation and immune responses. It is involved in the regulation of the production of pro-inflammatory cytokines and in the modulation of immune cell function.

Given the various functions of LIMD1, it is a promising biomarker for the diagnosis and treatment of various diseases, including neurodegenerative diseases. The misfolded proteins that are involved in these diseases can be detected using LIMD1 as a protein biomarker.

Conclusion

In conclusion, LIMD1 is a highly conserved protein that is involved in a wide range of cellular processes, including cell signaling, intracellular signaling, and protein synthesis. It is also involved in the regulation of the myosin ATPase, the unfolded protein response, and protein synthesis. The potential drug targeting of LIMD1 and its potential as a biomarker make it an attractive target for the development of new treatments for neurodegenerative diseases.

Protein Name: LIM Domain Containing 1

Functions: Adapter or scaffold protein which participates in the assembly of numerous protein complexes and is involved in several cellular processes such as cell fate determination, cytoskeletal organization, repression of gene transcription, cell-cell adhesion, cell differentiation, proliferation and migration. Positively regulates microRNA (miRNA)-mediated gene silencing and is essential for P-body formation and integrity. Acts as a hypoxic regulator by bridging an association between the prolyl hydroxylases and VHL enabling efficient degradation of HIF1A. Acts as a transcriptional corepressor for SNAI1- and SNAI2/SLUG-dependent repression of E-cadherin transcription. Negatively regulates the Hippo signaling pathway and antagonizes phosphorylation of YAP1. Inhibits E2F-mediated transcription, and suppresses the expression of the majority of genes with E2F1-responsive elements. Regulates osteoblast development, function, differentiation and stress osteoclastogenesis. Enhances the ability of TRAF6 to activate adapter protein complex 1 (AP-1) and negatively regulates the canonical Wnt receptor signaling pathway in osteoblasts. May act as a tumor suppressor by inhibiting cell proliferation

The "LIMD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LIMD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets